National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report
Консенсусный проект Национальных институтов здравоохранения по критериям проведения клинических исследований хронической реакции «трансплантат против хозяина»: V. Доклад рабочей группы по вспомогательной терапии и поддерживающей помощи за 2014 год
2015-04-06
SCID: 54.1/gjdg9hvr
Discuss with AI
ancillary therapychronic graft-versus-host diseaseclinical trialssupportive caresystemic immunosuppressive therapy
Figures from the paper
Abstract (AI)
The 2006 National Institutes of Health (NIH) Consensus paper presented recommendations by the Ancillary Therapy and Supportive Care Working Group to support clinical research trials in chronic graft-versus-host disease (GVHD). Topics covered in that inaugural effort included the prevention and management of infections and common complications of chronic GVHD, as well as recommendations for patient education and appropriate follow-up. Given the new literature that has emerged during the past 8 years, we made further organ-specific refinements to these guidelines. Minimum frequencies are suggested for monitoring key parameters relevant to chronic GVHD during systemic immunosuppressive therapy and, thereafter, referral to existing late effects consensus guidelines is advised. Using the framework of the prior consensus, the 2014 NIH recommendations are organized by organ or other relevant systems and graded according to the strength and quality of supporting evidence.
Key Findings
1
After systemic immunosuppression, the recommendations advise referral to existing consensus guidelines for late effects.
2
Organ-specific refinements address infection prevention, common chronic GVHD complications, patient education, and follow-up care.
3
Recommendations are organized by organ or relevant system and graded according to the strength and quality of supporting evidence.
4
The 2014 NIH consensus report updates recommendations for ancillary therapy and supportive care in chronic graft-versus-host disease clinical trials.
5
The guidelines incorporate new literature published during the eight years since the 2006 consensus recommendations.
6
The report suggests minimum monitoring frequencies for key parameters during systemic immunosuppressive therapy.
Research Object
Clinical trials in chronic graft-versus-host disease (GVHD)
Research Subject
organ-specific ancillary therapy and supportive-care recommendations, including infection and complication management, monitoring during systemic immunosuppression, patient education, and follow-up
Publication Details
Publication Date
2015-04-06
Journal
Publisher
ISSN
Cited by
241
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest